We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TCGL:NYSEMKTTechCreate Group Ltd. Analysis

Data as of 2026-05-27 - not real-time

$172.84

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

TechCreate Group Ltd. (TCGL) is trading at a price that vastly exceeds its underlying fundamentals. The stock’s price‑to‑book ratio is in the thousands and price‑to‑sales is in the high hundreds, while the company reports negative operating and net margins, and both operating and free cash flow are deeply in the red. Technical indicators reinforce the cautionary view: the Relative Strength Index is at an extreme high, the MACD histogram is negative and the signal line is bearish, and the 20‑day and 50‑day simple moving averages sit exactly at the current price, indicating a lack of directional momentum.
The recent fiscal‑year report highlighted a 54% revenue increase to roughly S$4.8 million, but this growth is modest compared to the market capitalization of over $3.5 billion. With a beta of roughly –2.4, the stock exhibits an inverse and highly volatile relationship to broader market moves, and the max drawdown of about 16% signals susceptibility to sharp declines. No dividend is paid, and analyst coverage is absent, further underscoring the speculative nature of the equity.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Extreme overbought RSI and bearish MACD signal
  • Severe overvaluation relative to book and sales
  • Negative cash flow and profitability

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued earnings deficits despite revenue growth
  • High beta indicating inverse market sensitivity
  • Lack of dividend and analyst coverage

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Fundamental financial weakness with negative margins
  • Unsustainable valuation multiples
  • Unclear path to profitability in a competitive tech‑infrastructure sector

Key Metrics & Analysis

Financial Health

Revenue Growth110.10%
Profit Margin-22.44%
ROE-17.86%
ROA-8.33%
Debt/Equity2.69
P/B Ratio4410.6
Op. Cash Flow$-5031822
Free Cash Flow$-2103698
Industry P/E40.4

Technical Analysis

TrendNeutral
RSI99.6
Support$172.84
Resistance$172.84
MA 20$172.84
MA 50$172.84
MA 200$93.65
MACDBearish
VolumeStable
Fear & Greed Index91.95

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta-2.42
0
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.